Class of Stock [Axis] Total current assets Total assets Asset Assets Total current liabilities Total liabilities Liability Liabilities Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Gross profit Operating loss Loss before income taxes Net loss Net gain(loss) Net loss Net Income(loss) Total comprehensive income(loss) for the period Balance (in Shares) Balance (in Shares) Number of ordinary share Equity Components [Axis] Net cash used in operating activities Net cash provided by(used in) investing activities Net cash provided by financing activities Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Organization and Nature of Business [Abstract] Ownership [Axis] Summary of Significant Accounting Policies [Abstract] Long-Lived Asset, Class [Axis] Statistical Measurement [Axis] Critical Accounting Estimates and Assumptions [Abstract] Financial Risk Management [Abstract] Total Maturity [Axis] Financial Instrument [Axis] Net borrowings Fair Value Measurements [Abstract] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Financial Instruments by Category [Abstract] Financial Instrument [Axis] Cash and Cash Equivalents [Abstract] Schedule of Cash and Cash Equivalents [Abstract[ Trade and Other Receivables, Net [Abstract] Schedule of Trade and Other Receivables, Net [Abstract] Net trade receivables Total Trade and other receivables, less allowance for credit losses of $60,013.69 and $62,370.40 as of June 30, 2026 and December 31, 2025, respectively Inventories, Net [Abstract] Schedule of Inventories [Abstract] Total inventories, net Inventories, net Other Financial Assets [Abstract] Asset Class [Axis] Other Assets [Abstract] Schedule of Other Assets [Abstract] Total other assets, current Other current assets Total other assets, non-current Equity Method Investment [Abstract] Investment, Name [Axis] Consolidated Entities [Axis] Equipment and Vehicles, Net [Abstract] Equipment and vehicles, net Equipment and vehicles, net Goodwill [Abstract] Schedule of Changes of Goodwill [Abstract] Beginning balance, Goodwill Ending balance, Goodwill Goodwill Intangible Assets, Net [Abstract] Intangible Asset, Finite-Lived, Class [Axis] Short-Term Borrowings [Abstract] Net borrowings (A) Long-Term Debt [Abstract] Post-Employment Benefits [Abstract] Related Party Transactions [Abstract] Related and Nonrelated Parties [Axis] Schedule of Compensations Paid or Accrued to Key Management of the Parent [Abstract] Administrative Expenses [Abstract] Schedule of Administrative Expenses [Abstract] Total Income Taxes [Abstract] Loss Per Share [Abstract] Income(loss) per share attributable to OSR Health, Inc. and subsidiaries Schedule of Basic and Diluted Loss Per Share [Abstract] Business Combinations [Abstract] Business Combination [Axis] Fair value of total identifiable asset Fair value of total identifiable liabilities Commitment and Contingencies [Abstract] Segment Reporting [Abstract] Subsequent Events [Abstract] Assets Current assets: Cash and cash equivalents Less: cash and cash equivalents Allowance for credit losses Less: Allowance for credit losses Prepaid income taxes Other current financial assets Total, Other Financial Assets Current Operating lease right-of-use assets, net Intangible assets, net Other non-current financial assets Total, Other Financial Assets Non-current Deferred tax assets Liabilities and Stockholders’ Equity Current liabilities: Short-term borrowing Short-term borrowings Short-term corporate bond Trade and other payables Accrued expenses Operating lease liabilities-current Other current liabilities Income taxes payable Derivative liabilities Financial liabilities at fair value through profit or loss Current portion - LT debt Long-term debt Operating lease liabilities- non-current Other non-current liabilities Deferred tax liabilities Stockholders’ equity: Common stock, $0.0001 par value, Authorized 100,000,000 shares; 35,118,692 shares and 26,597,769 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares issued (in Shares) Common stock, shares outstanding (in Shares) Additional paid-in capital Accumulated deficit Accumulated other comprehensive income Non-controlling interests Net sales Sales Revenue Cost of sales Selling, general, and administrative expenses Other income (expense): Interest income Other income Attributable to: OSR Health, Inc. and subsidiaries Net loss (A) Non-controlling interests Other comprehensive income for the period, net of tax Gain on foreign currency translation Attributable to: OSR Health, Inc. and subsidiaries Comprehensive loss Non-controlling interests Basic income(loss) per ordinary share (in Dollars per share) Basic loss per ordinary share (A/B) Foreign currency translation adjustment Business Combination Business Combination (in Shares) Changes in Excise tax Issuance of share capital Issuance of share capital (in Shares) Acquisition of non-controlling shares (in Shares) Common stock issued by ELOC program Common stock issued by ELOC program (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to cash used in operating activities: Income tax benefit Income tax benefit Depreciation Amortization Loss on inventory valuation Lease expense Bad debts Severance pay Commissions and professional fees Loss on change in fair value of financial liabilities Losses on change in fair value of financial liabilities Merger and acquisition costs Loss on foreign currency translation Losses on foreign currency transaction Changes in operating assets and liabilities: Increase (decrease) in trade and other payables Increase in accrued expenses Decrease in lease liabilities Increase (decrease) in tax payables Decrease in other liabilities Cash flows from investing activities: Decrease in deposits Disposal of equipment and vehicles Cash flows from financing activities: Proceeds from short-term borrowing Issuance of convertible bonds Proceeds from issuance of common stock Net change in cash and cash equivalents Effects of changes in exchange rate on cash and cash equivalents Supplemental disclosures of cash flow information: Cash paid for interest Cash paid for income taxes (net of refunds received) Interest expense Interest expense Other expenses Acquisition of non-controlling shares Gain on change in fair value of financial liabilities Gains on change in fair value of financial liabilities Gain on foreign currency translation Foreign exchange gains Decrease in trade and other receivables Decrease in inventories, net Decrease (increase) in other current assets Purchase of equipment and vehicles Increase in long-term loan